Oxana Jourkiv
Child & Adolescent Psychiatry · Washington, DCNPI 1265631071
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 593 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 593 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- Lundbeck LLC$910
- Johnson & Johnson$883
- Supernus Pharmaceuticals, Inc.$806
- Tris Pharma Inc$663
- plus $6K from 24 others
What the payments were for
- Food & beverage$11,23499%
- Education$1231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 65 | $1,101 |
| AbbVie(2 entities) | 65 | $1,073 |
| Lundbeck LLC | 46 | $910 |
| Johnson & Johnson | 35 | $883 |
| Supernus Pharmaceuticals, Inc. | 30 | $806 |
| Tris Pharma Inc | 47 | $663 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $610 |
| Ironshore Pharmaceuticals Inc. | 31 | $608 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $601 |
| Bausch Health US, LLC | 29 | $588 |
| Teva Pharmaceuticals USA, Inc. | 25 | $584 |
| Vanda Pharmaceuticals Inc. | 15 | $486 |
| Corium, LLC | 23 | $464 |
| Alkermes, Inc. | 18 | $329 |
| Shire North American Group Inc | 20 | $245 |
| Neurocrine Biosciences, Inc. | 9 | $230 |
| Sunovion Pharmaceuticals Inc. | 14 | $223 |
| Collegium Pharmaceutical, Inc. | 9 | $193 |
| Neos Therapeutics, LP | 9 | $172 |
| Axsome Therapeutics, Inc. | 8 | $155 |
| Adlon Therapeutics L.p. | 10 | $141 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Almatica Pharma LLC | 2 | $43 |
| Noven Therapeutics, LLC | 1 | $20 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| TMS Neurohealth Centers Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,357 in reported general payments places this provider in the 95th percentile of 21 child & adolescent psychiatry providers in District of Columbia.
See all child & adolescent psychiatry providers in District of Columbia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 17 | $376 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $324 |
| Trazodone Hcl | 19 | $228 |
| Lamotrigine | 19 | $198 |
| Clonazepam | 15 | $89 |
| Fluoxetine Hcl | 15 | $85 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Washington
- Aneela KaziWashington$3K
- Christopher RaczynskiWashington$2K
- Brent AndersonWashington$1K
- Estela GonzalesWashington$1K
- Tracy DasWashington$872
- Fredrik Palmer PicardWashington$794
- Rongrong TaoWashington$676
- Mattie WhiteWashington$555
- Shahbaz KhanWashington$426
- Xiaoxi OuyangWashington$242
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.